LJUBLJANA (Slovenia), February 25 (SeeNews) – Krka Sverige, the Swedish subsidiary of Slovenia's drug maker Krka [LJE:KRKG], has caused to London-listed AstraZeneca damages of 50 million Danish crowns (6.7 million euro) due to patent infringement, according to a decision of Commercial Court in Copenhagen, cited by Krka on Thursday.